Sechenov School
Home › Microbiology › Sporotrichosis

Sporotrichosis

Sporothrix schenckii

For medical students2 min readUpdated 2026-10-10

A chronic fungal infection (also known as Schenck's disease) primarily affecting the skin, subcutaneous tissue, and lymph nodes. It is caused by the dimorphic fungus Sporothrix schenckii, which alters its morphology depending on temperature and environmental conditions.

Causative agentDimorphic fungus Sporothrix schenckii (discovered in 1898)
LocalizationSkin, subcutaneous tissue, lymph nodes (less commonly visceral forms)
Alternative name"Rose gardener's disease"
Specific therapyPotassium iodide, amphotericin B, itraconazole

Morphology and Pathogen Dimorphism

The fungus Sporothrix schenckii exhibits thermal dimorphism, existing in two distinct forms depending on environmental conditions:

Epidemiology and Transmission

The environmental reservoir includes soil, decaying wood, plants, and water. In nature, the fungus thrives in its mycelial form.

Individuals engaged in agricultural work are at higher risk. Transmission occurs via two main routes:

Pathogenesis and Clinical Presentation

The site of cutaneous trauma serves as the portal of entry. A primary lesion develops here as firm, painless nodules, abscesses, or irregular ulcers.

Further dissemination occurs via lymphatic spread. Secondary nodules prone to ulceration appear along proximal lymphatic vessels. The predominant clinical presentation is lymphocutaneous sporotrichosis.

Deep dissemination leads to visceral forms, involving the lungs, bones, abdominal organs, and central nervous system.

Immunity and Diagnostics

The host response involves antibody production (humoral immunity) and delayed-type hypersensitivity (DTH). The primary defense mechanism relies on phagocytosis of the fungal elements by macrophages and neutrophils.

Diagnostic confirmation involves:

  1. Microscopy: Identification of yeast cells and asteroid bodies in smears or biopsy specimens.
  2. Culture: Isolation of the pure culture demonstrating thermal dimorphism. Incubation at 22–25 °C for 7–10 days yields the mycelial phase, while incubation at 37 °C yields the yeast phase.
  3. Animal inoculation: Intratesticular inoculation of guinea pigs to confirm the transition from mycelium to yeast.
  4. Serology: Detection of serum antibodies (ELISA, agglutination assays, precipitation tests).

Frequently asked questions

What clinical manifestations are typical of visceral sporotrichosis?

Visceral sporotrichosis develops when the pathogen disseminates, affecting various internal organs. The clinical manifestations depend on the localization of the pathological process:

  • Lungs — respiratory involvement, which can also present as primary pulmonary sporotrichosis.
  • Bones — involvement of osseous tissue.
  • Abdominal organs — pathology within abdominal viscera.
  • Brain — central nervous system involvement.
What immunological defense mechanisms are activated during sporotrichosis?

Both humoral and cell-mediated immune mechanisms are engaged during sporotrichosis:

  • Humoral response — production of specific antibodies.
  • Cellular response — development of delayed-type hypersensitivity (DTH).
  • Phagocytosis — engulfment of fungal cells by neutrophils and macrophages.
What is the dimorphic nature of Sporothrix schenckii?

It refers to the ability to change morphology based on temperature. At 37 °C within human tissue, it exists as a yeast (tissue form), whereas in the environment or on culture media at 18–30 °C, it grows as a mycelium (culture form).

What are asteroid bodies?

They are characteristic structures seen in the tissue form of sporotrichosis: yeast-like cells surrounded by a radiating, star-like eosinophilic corona.

What is the characteristic pathway of dissemination for sporotrichosis in the body?

The pathogen spreads via the lymphatic system, forming secondary ulcerating nodules along the path of proximal lymphatic vessels.

Go deeper

More topics in Microbiology

Food Microflora and ContaminationSkin Immune SystemSystemic Lupus ErythematosusViral PathogenicitySerological Diagnostic MethodsImmunity in Viral Respiratory InfectionsHuman Prion DiseasesChlamydiaBacterial RespirationBacterial Gene Transfer MechanismsClusters of Differentiation (CD Markers): Anatomy and FunctionProbiotics: Mechanisms, Indications and Clinical ApplicationMicrobiology →